Article thumbnail

Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

By Guillermo Quintero Aldana and Mercedes Salgado Fernández
Publisher: 'Springer Science and Business Media LLC'
Year: 2014
DOI identifier: 10.1186/1471-2...
OAI identifier: oai:runa.sergas.gal:20.500.11940/1144
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://dx.doi.org/10.1186/1471... (external link)
  • http://hdl.handle.net/20.500.1... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.